ctDNA and Metabolites in CSF as Early Biomarkers of Secondary CNS Involvement in Diffuse Large B-cell Lymphoma
Clinical trial NCT04112238 · UNKNOWN
Trial details
- NCT number
- NCT04112238
- Sponsor
- Herlev Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-08-29
- Primary completion
- 2023-06-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.